Kira Pharmaceuticals
Phase 2The complement system is complex and implicated in a large number of autoimmune and inflammatory conditions across hematology, nephrology, neurology, dermatology, ophthalmology and many other disease areas. However, given the complex biology and abundance of proteins involved in the complement system, it has historically been challenging to develop effective and convenient therapies to modulate the complement system.
About
The complement system is complex and implicated in a large number of autoimmune and inflammatory conditions across hematology, nephrology, neurology, dermatology, ophthalmology and many other disease areas. However, given the complex biology and abundance of proteins involved in the complement system, it has historically been challenging to develop effective and convenient therapies to modulate the complement system.
Funding History
2Total raised: $152M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile